Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 35 | 2024 | 3615 | 3.780 |
Why?
|
Neuroblastoma | 14 | 2024 | 1250 | 3.510 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 10 | 2023 | 104 | 2.280 |
Why?
|
RNA-Binding Protein EWS | 12 | 2023 | 210 | 2.270 |
Why?
|
Gene Expression Regulation, Neoplastic | 29 | 2024 | 8554 | 2.100 |
Why?
|
Xenograft Model Antitumor Assays | 24 | 2021 | 3605 | 1.930 |
Why?
|
Oncogene Proteins, Fusion | 17 | 2023 | 1609 | 1.870 |
Why?
|
Cell Line, Tumor | 61 | 2024 | 16990 | 1.810 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 10 | 2023 | 382 | 1.680 |
Why?
|
Leukemia | 9 | 2021 | 1522 | 1.670 |
Why?
|
Receptor, Notch1 | 7 | 2020 | 496 | 1.470 |
Why?
|
Bone Neoplasms | 9 | 2022 | 2529 | 1.450 |
Why?
|
Cyclin-Dependent Kinase 4 | 5 | 2019 | 561 | 1.420 |
Why?
|
Protein Kinase Inhibitors | 23 | 2023 | 5672 | 1.240 |
Why?
|
fms-Like Tyrosine Kinase 3 | 6 | 2020 | 495 | 1.200 |
Why?
|
Antineoplastic Agents | 26 | 2024 | 13642 | 1.160 |
Why?
|
Drug Resistance, Neoplasm | 12 | 2021 | 5305 | 1.130 |
Why?
|
Gene Expression Regulation, Leukemic | 8 | 2019 | 651 | 1.030 |
Why?
|
Molecular Targeted Therapy | 14 | 2024 | 2811 | 1.030 |
Why?
|
Gene Amplification | 8 | 2024 | 1089 | 1.010 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2020 | 2425 | 1.010 |
Why?
|
Glycine Hydroxymethyltransferase | 2 | 2022 | 32 | 0.960 |
Why?
|
Glycogen Synthase Kinase 3 | 6 | 2022 | 411 | 0.880 |
Why?
|
Triazoles | 6 | 2024 | 903 | 0.810 |
Why?
|
Cell Cycle Proteins | 12 | 2024 | 3449 | 0.810 |
Why?
|
Azepines | 4 | 2019 | 329 | 0.800 |
Why?
|
Creatine Kinase | 3 | 2023 | 685 | 0.800 |
Why?
|
Sulfonamides | 3 | 2024 | 1979 | 0.790 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2024 | 477 | 0.780 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2872 | 0.760 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 5 | 2017 | 359 | 0.760 |
Why?
|
Enzyme Inhibitors | 8 | 2023 | 3713 | 0.740 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.740 |
Why?
|
Genome, Human | 6 | 2021 | 4425 | 0.730 |
Why?
|
Histone Deacetylase Inhibitors | 4 | 2024 | 774 | 0.730 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 641 | 0.720 |
Why?
|
Cell Differentiation | 14 | 2024 | 11530 | 0.700 |
Why?
|
Indazoles | 2 | 2019 | 304 | 0.700 |
Why?
|
Transcription Factors | 18 | 2023 | 12130 | 0.690 |
Why?
|
Cell Survival | 15 | 2022 | 5791 | 0.680 |
Why?
|
Cell Proliferation | 23 | 2021 | 10451 | 0.670 |
Why?
|
Folic Acid | 3 | 2021 | 1323 | 0.670 |
Why?
|
Mice, Inbred NOD | 11 | 2021 | 1827 | 0.660 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2023 | 1551 | 0.660 |
Why?
|
Neoplasms | 17 | 2024 | 22173 | 0.660 |
Why?
|
Drug Synergism | 7 | 2019 | 1757 | 0.650 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2019 | 350 | 0.640 |
Why?
|
Aminopyridines | 4 | 2019 | 573 | 0.620 |
Why?
|
Epigenesis, Genetic | 6 | 2024 | 3801 | 0.620 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2018 | 2057 | 0.610 |
Why?
|
Drug Discovery | 4 | 2022 | 1051 | 0.610 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2021 | 655 | 0.610 |
Why?
|
Mutation | 23 | 2023 | 30053 | 0.600 |
Why?
|
Proto-Oncogene Proteins c-myc | 5 | 2020 | 988 | 0.600 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2023 | 2917 | 0.590 |
Why?
|
Genomics | 10 | 2016 | 5821 | 0.580 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 304 | 0.580 |
Why?
|
Phenylenediamines | 1 | 2018 | 88 | 0.580 |
Why?
|
Mice | 49 | 2024 | 81539 | 0.580 |
Why?
|
Gene Expression Profiling | 14 | 2021 | 9420 | 0.570 |
Why?
|
Trans-Activators | 2 | 2024 | 2856 | 0.560 |
Why?
|
High-Throughput Screening Assays | 5 | 2019 | 934 | 0.560 |
Why?
|
Small Molecule Libraries | 7 | 2020 | 733 | 0.560 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9280 | 0.550 |
Why?
|
Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 10 | 0.550 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2020 | 455 | 0.550 |
Why?
|
Animals | 64 | 2024 | 168475 | 0.540 |
Why?
|
Proto-Oncogenes | 2 | 2017 | 321 | 0.530 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 380 | 0.530 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2024 | 2827 | 0.530 |
Why?
|
Oncogene Proteins | 4 | 2014 | 719 | 0.520 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 231 | 0.490 |
Why?
|
Neoplasm Proteins | 7 | 2021 | 3617 | 0.490 |
Why?
|
Humans | 144 | 2024 | 761596 | 0.490 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1171 | 0.470 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.470 |
Why?
|
Nuclear Proteins | 9 | 2023 | 5799 | 0.460 |
Why?
|
Mice, Nude | 8 | 2019 | 3614 | 0.460 |
Why?
|
Signal Transduction | 23 | 2024 | 23447 | 0.460 |
Why?
|
Casein Kinase I | 1 | 2014 | 46 | 0.460 |
Why?
|
Pyrimidines | 5 | 2021 | 3028 | 0.460 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.450 |
Why?
|
Apoptosis | 17 | 2024 | 9490 | 0.450 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2019 | 223 | 0.450 |
Why?
|
Antimetabolites, Antineoplastic | 3 | 2021 | 646 | 0.450 |
Why?
|
Cyclin D1 | 1 | 2015 | 451 | 0.440 |
Why?
|
U937 Cells | 7 | 2020 | 261 | 0.440 |
Why?
|
HL-60 Cells | 7 | 2016 | 363 | 0.430 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4615 | 0.430 |
Why?
|
Transcription, Genetic | 6 | 2019 | 7593 | 0.430 |
Why?
|
Purines | 1 | 2016 | 607 | 0.430 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 72 | 0.430 |
Why?
|
Drug Screening Assays, Antitumor | 5 | 2020 | 718 | 0.420 |
Why?
|
Histone Deacetylase 1 | 1 | 2013 | 133 | 0.410 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 186 | 0.410 |
Why?
|
Lactams | 1 | 2013 | 156 | 0.410 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 128 | 0.410 |
Why?
|
Mice, SCID | 6 | 2021 | 2626 | 0.400 |
Why?
|
Proteomics | 6 | 2022 | 3848 | 0.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11742 | 0.390 |
Why?
|
DNA-Binding Proteins | 8 | 2021 | 9610 | 0.350 |
Why?
|
Tumor Cells, Cultured | 8 | 2021 | 6131 | 0.340 |
Why?
|
Up-Regulation | 3 | 2017 | 4125 | 0.340 |
Why?
|
RNA Interference | 8 | 2018 | 2832 | 0.320 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2009 | 135 | 0.320 |
Why?
|
Cytarabine | 2 | 2009 | 698 | 0.310 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4415 | 0.310 |
Why?
|
Proteins | 5 | 2021 | 6032 | 0.310 |
Why?
|
Quinazolines | 4 | 2019 | 1371 | 0.300 |
Why?
|
Carrier Proteins | 1 | 2021 | 4937 | 0.300 |
Why?
|
Retinoids | 1 | 2008 | 99 | 0.300 |
Why?
|
RNA, Small Interfering | 8 | 2018 | 3430 | 0.300 |
Why?
|
Acetylation | 3 | 2024 | 1055 | 0.300 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2226 | 0.300 |
Why?
|
Chromatin | 6 | 2024 | 2961 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2018 | 3639 | 0.290 |
Why?
|
HEK293 Cells | 8 | 2021 | 4281 | 0.280 |
Why?
|
Rhabdoid Tumor | 2 | 2019 | 210 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-ets | 6 | 2023 | 315 | 0.280 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 1997 | 430 | 0.280 |
Why?
|
Cell Cycle | 5 | 2023 | 2932 | 0.270 |
Why?
|
Galectin 3 | 1 | 2008 | 240 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1406 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3779 | 0.270 |
Why?
|
Down-Regulation | 5 | 2018 | 2919 | 0.260 |
Why?
|
Thapsigargin | 2 | 2017 | 102 | 0.260 |
Why?
|
Phosphorylation | 8 | 2019 | 8321 | 0.250 |
Why?
|
Histones | 5 | 2024 | 2580 | 0.250 |
Why?
|
Gene Expression | 9 | 2022 | 7581 | 0.250 |
Why?
|
Cell Death | 3 | 2019 | 1679 | 0.240 |
Why?
|
Child | 26 | 2024 | 80158 | 0.240 |
Why?
|
Gene Knockdown Techniques | 4 | 2022 | 1612 | 0.240 |
Why?
|
Protein Stability | 3 | 2021 | 578 | 0.240 |
Why?
|
Hydrazines | 2 | 2024 | 224 | 0.230 |
Why?
|
Leukemia, Myeloid | 3 | 2015 | 694 | 0.230 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2016 | 0.230 |
Why?
|
Flow Cytometry | 6 | 2017 | 5870 | 0.230 |
Why?
|
Genes, Tumor Suppressor | 3 | 2023 | 1062 | 0.230 |
Why?
|
Ubiquitination | 3 | 2024 | 1007 | 0.220 |
Why?
|
Cell Lineage | 5 | 2024 | 2557 | 0.220 |
Why?
|
Gene Knockout Techniques | 3 | 2021 | 802 | 0.210 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2023 | 48 | 0.210 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2024 | 200 | 0.210 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1334 | 0.210 |
Why?
|
Blotting, Western | 3 | 2017 | 5035 | 0.210 |
Why?
|
Translocation, Genetic | 6 | 2018 | 1393 | 0.210 |
Why?
|
Gene Dosage | 2 | 2017 | 1218 | 0.200 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2023 | 174 | 0.200 |
Why?
|
DNA Methylation | 4 | 2024 | 4399 | 0.200 |
Why?
|
Vaccinia | 1 | 2022 | 71 | 0.200 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2024 | 168 | 0.200 |
Why?
|
Histone Acetyltransferases | 1 | 2024 | 336 | 0.200 |
Why?
|
Protein Kinases | 2 | 2020 | 1608 | 0.200 |
Why?
|
Cystine | 1 | 2022 | 94 | 0.200 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 4576 | 0.190 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Immunologic Memory | 1 | 2008 | 1359 | 0.190 |
Why?
|
POU Domain Factors | 1 | 2021 | 47 | 0.190 |
Why?
|
Wilms Tumor | 1 | 2024 | 379 | 0.190 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 305 | 0.180 |
Why?
|
Karyopherins | 2 | 2024 | 133 | 0.180 |
Why?
|
Creatine | 1 | 2023 | 427 | 0.180 |
Why?
|
Pharmaceutical Preparations | 1 | 2009 | 1089 | 0.180 |
Why?
|
Asparaginase | 2 | 2019 | 240 | 0.180 |
Why?
|
CDC2 Protein Kinase | 1 | 2021 | 213 | 0.170 |
Why?
|
Diphenylamine | 1 | 2019 | 49 | 0.170 |
Why?
|
Morpholines | 2 | 2016 | 581 | 0.170 |
Why?
|
Homeodomain Proteins | 2 | 2021 | 2418 | 0.170 |
Why?
|
Trisomy | 1 | 2021 | 260 | 0.170 |
Why?
|
DNA Replication | 2 | 2024 | 1418 | 0.170 |
Why?
|
Female | 31 | 2021 | 392705 | 0.170 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 150 | 0.170 |
Why?
|
Dipeptides | 2 | 2018 | 391 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2022 | 335 | 0.160 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2019 | 1693 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 368 | 0.160 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.160 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2020 | 276 | 0.160 |
Why?
|
T-Lymphocytes | 7 | 2023 | 10194 | 0.160 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2019 | 120 | 0.160 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2018 | 41 | 0.160 |
Why?
|
Thiophenes | 2 | 2018 | 569 | 0.160 |
Why?
|
Transfection | 4 | 2015 | 5774 | 0.160 |
Why?
|
Hematologic Neoplasms | 1 | 2011 | 1896 | 0.160 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 305 | 0.160 |
Why?
|
Bepridil | 1 | 2018 | 12 | 0.160 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2022 | 1136 | 0.150 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2018 | 2865 | 0.150 |
Why?
|
Folate Receptor 2 | 1 | 2017 | 5 | 0.150 |
Why?
|
Repressor Proteins | 6 | 2018 | 2986 | 0.150 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2022 | 790 | 0.150 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 326 | 0.150 |
Why?
|
Zebrafish | 5 | 2021 | 3008 | 0.150 |
Why?
|
Anilides | 1 | 2021 | 411 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 347 | 0.150 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2020 | 329 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 477 | 0.150 |
Why?
|
Models, Genetic | 3 | 2017 | 3442 | 0.150 |
Why?
|
Gene Duplication | 2 | 2021 | 314 | 0.150 |
Why?
|
HMGB Proteins | 1 | 2017 | 45 | 0.150 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 682 | 0.150 |
Why?
|
DNA Damage | 3 | 2023 | 2449 | 0.150 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5790 | 0.150 |
Why?
|
Glioma | 2 | 2022 | 3455 | 0.140 |
Why?
|
Molecular Structure | 4 | 2021 | 1880 | 0.140 |
Why?
|
Acute Disease | 4 | 2018 | 7237 | 0.140 |
Why?
|
I-kappa B Kinase | 1 | 2018 | 250 | 0.140 |
Why?
|
Peptide Hydrolases | 1 | 2020 | 624 | 0.140 |
Why?
|
Bone Marrow | 2 | 2019 | 2911 | 0.140 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.140 |
Why?
|
Integrin beta3 | 2 | 2017 | 120 | 0.140 |
Why?
|
Benzamides | 2 | 2019 | 1371 | 0.140 |
Why?
|
Tretinoin | 2 | 2013 | 519 | 0.140 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2024 | 858 | 0.140 |
Why?
|
Oncogenes | 3 | 2022 | 1222 | 0.140 |
Why?
|
Pyridines | 4 | 2020 | 2875 | 0.140 |
Why?
|
Benzothiazoles | 1 | 2017 | 247 | 0.140 |
Why?
|
Protease Inhibitors | 1 | 2020 | 754 | 0.130 |
Why?
|
Polyethylene Glycols | 2 | 2019 | 1189 | 0.130 |
Why?
|
Open Reading Frames | 1 | 2019 | 815 | 0.130 |
Why?
|
Peptides, Cyclic | 1 | 2018 | 392 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10766 | 0.130 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1134 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.130 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2015 | 25 | 0.130 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4369 | 0.130 |
Why?
|
Clone Cells | 1 | 2019 | 1659 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 2 | 1996 | 2805 | 0.120 |
Why?
|
Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
Mice, Inbred BALB C | 4 | 2020 | 6214 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2457 | 0.120 |
Why?
|
Pyrimidinones | 1 | 2017 | 385 | 0.120 |
Why?
|
Calcium Channel Blockers | 1 | 2018 | 694 | 0.120 |
Why?
|
Wnt Proteins | 1 | 2018 | 718 | 0.120 |
Why?
|
Enhancer Elements, Genetic | 1 | 2021 | 1363 | 0.120 |
Why?
|
Aniline Compounds | 1 | 2020 | 1069 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2014 | 12794 | 0.120 |
Why?
|
Gene Rearrangement | 2 | 2022 | 1125 | 0.120 |
Why?
|
Nucleic Acid Conformation | 1 | 2018 | 902 | 0.120 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 732 | 0.120 |
Why?
|
Cerebellar Neoplasms | 1 | 2019 | 586 | 0.110 |
Why?
|
DNA Copy Number Variations | 3 | 2017 | 2020 | 0.110 |
Why?
|
Triazines | 1 | 2016 | 311 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2019 | 678 | 0.110 |
Why?
|
Niacinamide | 1 | 2016 | 413 | 0.110 |
Why?
|
Microtubule-Associated Proteins | 2 | 1996 | 1076 | 0.110 |
Why?
|
Pyrazines | 1 | 2019 | 1202 | 0.110 |
Why?
|
NF-kappa B | 1 | 2022 | 2490 | 0.110 |
Why?
|
Stress, Physiological | 1 | 2021 | 1403 | 0.110 |
Why?
|
Endocytosis | 1 | 2017 | 957 | 0.110 |
Why?
|
Genomic Instability | 1 | 2017 | 709 | 0.110 |
Why?
|
DNA, Neoplasm | 3 | 2014 | 1745 | 0.110 |
Why?
|
Biological Transport | 1 | 2017 | 2091 | 0.110 |
Why?
|
Gene Targeting | 1 | 2016 | 838 | 0.100 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 529 | 0.100 |
Why?
|
Neurogenesis | 1 | 2019 | 863 | 0.100 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1626 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1486 | 0.100 |
Why?
|
Osteosarcoma | 1 | 2018 | 897 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 789 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 3 | 2021 | 17904 | 0.100 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2330 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 558 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 372 | 0.100 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 750 | 0.100 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 84 | 0.100 |
Why?
|
Mitochondria | 3 | 2023 | 3624 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 3 | 2019 | 4514 | 0.100 |
Why?
|
Protein Binding | 3 | 2018 | 9353 | 0.090 |
Why?
|
Inhibitory Concentration 50 | 2 | 2009 | 465 | 0.090 |
Why?
|
Nucleotides | 2 | 2024 | 454 | 0.090 |
Why?
|
Protein Isoforms | 3 | 2023 | 1699 | 0.090 |
Why?
|
BRCA1 Protein | 1 | 2018 | 1158 | 0.090 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.090 |
Why?
|
Proteome | 2 | 2018 | 1862 | 0.090 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20100 | 0.090 |
Why?
|
Prognosis | 7 | 2022 | 29629 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6815 | 0.090 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1704 | 0.090 |
Why?
|
Interferon Regulatory Factors | 2 | 2022 | 261 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 622 | 0.090 |
Why?
|
S Phase | 2 | 2024 | 421 | 0.090 |
Why?
|
Point Mutation | 1 | 1996 | 1595 | 0.090 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.090 |
Why?
|
Gene Library | 1 | 2013 | 1059 | 0.090 |
Why?
|
Gene Deletion | 3 | 1997 | 2665 | 0.090 |
Why?
|
Lentivirus | 1 | 2013 | 508 | 0.090 |
Why?
|
Exons | 1 | 1996 | 2391 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2020 | 22174 | 0.080 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2014 | 620 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1892 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 993 | 0.080 |
Why?
|
Cell Movement | 1 | 2021 | 5205 | 0.080 |
Why?
|
Dexamethasone | 1 | 2016 | 1948 | 0.080 |
Why?
|
Calcium Channels | 1 | 2013 | 620 | 0.080 |
Why?
|
Male | 21 | 2021 | 360846 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2019 | 1394 | 0.080 |
Why?
|
Adult | 11 | 2024 | 221210 | 0.080 |
Why?
|
Doxorubicin | 3 | 2024 | 2224 | 0.080 |
Why?
|
Mucin-1 | 1 | 2013 | 540 | 0.080 |
Why?
|
Fluorouracil | 1 | 2014 | 1642 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2021 | 11076 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18255 | 0.080 |
Why?
|
Structure-Activity Relationship | 3 | 2021 | 3076 | 0.080 |
Why?
|
Immunomagnetic Separation | 1 | 2008 | 79 | 0.080 |
Why?
|
Receptors, CCR7 | 1 | 2008 | 107 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1246 | 0.080 |
Why?
|
Cysteine | 2 | 2023 | 891 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4740 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1659 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4251 | 0.070 |
Why?
|
Oxazines | 1 | 2009 | 350 | 0.070 |
Why?
|
Fluorometry | 1 | 2007 | 99 | 0.070 |
Why?
|
Chromosomes, Human, Pair 21 | 3 | 2014 | 228 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12690 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1640 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13510 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.060 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2008 | 330 | 0.060 |
Why?
|
Immunoblotting | 1 | 2009 | 1646 | 0.060 |
Why?
|
Biology | 1 | 2007 | 290 | 0.060 |
Why?
|
Computational Biology | 1 | 2017 | 3517 | 0.060 |
Why?
|
Drosophila | 1 | 2013 | 1495 | 0.060 |
Why?
|
Binding Sites | 3 | 2023 | 6056 | 0.060 |
Why?
|
Tyrosine | 1 | 2009 | 1440 | 0.060 |
Why?
|
Sarcoma | 1 | 2016 | 1801 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2007 | 750 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 1996 | 319 | 0.060 |
Why?
|
Receptors, Retinoic Acid | 1 | 2005 | 224 | 0.060 |
Why?
|
Molecular Weight | 1 | 2007 | 2186 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2386 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2009 | 720 | 0.060 |
Why?
|
Survival Rate | 2 | 2020 | 12723 | 0.060 |
Why?
|
Myeloid Cells | 1 | 2009 | 823 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2894 | 0.060 |
Why?
|
Microspheres | 1 | 2007 | 784 | 0.060 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2005 | 251 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2006 | 424 | 0.060 |
Why?
|
Cell Culture Techniques | 2 | 2008 | 1668 | 0.060 |
Why?
|
STAT Transcription Factors | 1 | 2024 | 188 | 0.050 |
Why?
|
Computer Simulation | 1 | 2017 | 6241 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 1 | 2009 | 1188 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2021 | 18966 | 0.050 |
Why?
|
Time Factors | 3 | 2015 | 39969 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Protein Conformation | 1 | 2011 | 3968 | 0.050 |
Why?
|
Janus Kinases | 1 | 2024 | 248 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2018 | 4024 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2024 | 436 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10774 | 0.050 |
Why?
|
Formates | 1 | 2022 | 40 | 0.050 |
Why?
|
Protein Array Analysis | 1 | 2004 | 400 | 0.050 |
Why?
|
Daunorubicin | 1 | 2022 | 157 | 0.050 |
Why?
|
Sulfasalazine | 1 | 2022 | 84 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2023 | 303 | 0.050 |
Why?
|
Base Sequence | 4 | 2013 | 12441 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 412 | 0.050 |
Why?
|
Alleles | 1 | 2013 | 6864 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.050 |
Why?
|
E1A-Associated p300 Protein | 1 | 2022 | 123 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2007 | 997 | 0.050 |
Why?
|
Microsomes, Liver | 1 | 2021 | 173 | 0.050 |
Why?
|
Genetic Techniques | 1 | 2004 | 428 | 0.050 |
Why?
|
Histocompatibility Antigens | 1 | 2022 | 464 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3816 | 0.050 |
Why?
|
Medical Oncology | 3 | 2020 | 2321 | 0.050 |
Why?
|
Tacrolimus Binding Protein 1A | 1 | 2020 | 40 | 0.050 |
Why?
|
Vaccinia virus | 1 | 2022 | 331 | 0.050 |
Why?
|
Cohort Studies | 2 | 2021 | 41495 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4758 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 232 | 0.040 |
Why?
|
beta Catenin | 2 | 2018 | 1040 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1079 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 871 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 364 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 9177 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 323 | 0.040 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2021 | 453 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 17635 | 0.040 |
Why?
|
Nervous System | 1 | 2022 | 545 | 0.040 |
Why?
|
Prospective Studies | 2 | 2021 | 54423 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1903 | 0.040 |
Why?
|
Smad2 Protein | 1 | 2019 | 145 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14417 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 431 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2015 | 3597 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2020 | 233 | 0.040 |
Why?
|
Glycine | 1 | 2022 | 663 | 0.040 |
Why?
|
Indoles | 2 | 2019 | 1833 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2019 | 310 | 0.040 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 2 | 1997 | 92 | 0.040 |
Why?
|
Neurons | 1 | 2017 | 9463 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2022 | 1435 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 293 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2016 | 2021 | 0.040 |
Why?
|
DNA Helicases | 1 | 2022 | 851 | 0.040 |
Why?
|
Karyotyping | 1 | 2019 | 1171 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 976 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2021 | 836 | 0.030 |
Why?
|
Models, Molecular | 2 | 2017 | 5439 | 0.030 |
Why?
|
Drug Resistance | 1 | 2022 | 1596 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2017 | 426 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2018 | 13381 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2016 | 56 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 329 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2015 | 115 | 0.030 |
Why?
|
United States | 2 | 2021 | 72340 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 416 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6484 | 0.030 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1995 | 113 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1036 | 0.030 |
Why?
|
Piperazines | 2 | 2016 | 2523 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 883 | 0.030 |
Why?
|
Embryo, Nonmammalian | 1 | 2019 | 906 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2015 | 155 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2014 | 15 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.030 |
Why?
|
Chemotaxis | 1 | 2018 | 598 | 0.030 |
Why?
|
Genes, Essential | 1 | 2016 | 185 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2020 | 1229 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2139 | 0.030 |
Why?
|
Child, Preschool | 5 | 2018 | 42232 | 0.030 |
Why?
|
Ribosomal Protein S6 | 1 | 2014 | 71 | 0.030 |
Why?
|
Neoplastic Stem Cells | 1 | 2022 | 1351 | 0.030 |
Why?
|
Epigenomics | 1 | 2020 | 943 | 0.030 |
Why?
|
Cell Line | 3 | 2019 | 15601 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1093 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2015 | 544 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2019 | 1386 | 0.030 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 58984 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2112 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3397 | 0.030 |
Why?
|
Solubility | 1 | 2015 | 1091 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2014 | 126 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2022 | 4807 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3420 | 0.030 |
Why?
|
Software | 1 | 2007 | 4434 | 0.030 |
Why?
|
DNA Replication Timing | 1 | 2013 | 34 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1563 | 0.030 |
Why?
|
Adolescent | 6 | 2023 | 88326 | 0.030 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 95 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2018 | 21019 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14665 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 787 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1321 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1989 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1561 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1768 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 1745 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2397 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1664 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2019 | 888 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2023 | 2882 | 0.020 |
Why?
|
DNA Repair | 1 | 2021 | 2046 | 0.020 |
Why?
|
Aneuploidy | 1 | 1995 | 552 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1964 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1084 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.020 |
Why?
|
Infant | 4 | 2018 | 36193 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3124 | 0.020 |
Why?
|
Isoenzymes | 1 | 2015 | 1687 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1048 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1995 | 1494 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2013 | 957 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 488 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8466 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2019 | 2050 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2013 | 64685 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1995 | 2510 | 0.020 |
Why?
|
Genetic Markers | 1 | 1995 | 2601 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6312 | 0.020 |
Why?
|
Survival Analysis | 2 | 2018 | 10090 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2010 | 1141 | 0.020 |
Why?
|
3T3 Cells | 1 | 2010 | 1085 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 1060 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 1996 | 4111 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2643 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1860 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 1642 | 0.020 |
Why?
|
Phenotype | 2 | 2016 | 16592 | 0.020 |
Why?
|
Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
Pentacyclic Triterpenes | 1 | 2006 | 35 | 0.020 |
Why?
|
Limonins | 1 | 2006 | 24 | 0.020 |
Why?
|
Helix-Loop-Helix Motifs | 2 | 1997 | 96 | 0.020 |
Why?
|
Aged | 2 | 2017 | 169310 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3810 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4652 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9542 | 0.020 |
Why?
|
Triterpenes | 1 | 2006 | 76 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.020 |
Why?
|
Benzoquinones | 1 | 2006 | 198 | 0.020 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 2 | 1997 | 178 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4915 | 0.020 |
Why?
|
Middle Aged | 2 | 2017 | 220921 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3878 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2006 | 318 | 0.010 |
Why?
|
Artifacts | 1 | 2013 | 1911 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2006 | 1302 | 0.010 |
Why?
|
Young Adult | 2 | 2023 | 59260 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2009 | 0.010 |
Why?
|
Pediatrics | 1 | 2019 | 3589 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3093 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3272 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2006 | 678 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80647 | 0.010 |
Why?
|
Peptides | 1 | 2013 | 4358 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2820 | 0.010 |
Why?
|
Cloning, Molecular | 2 | 1997 | 4174 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2007 | 1742 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10212 | 0.010 |
Why?
|
Genes, abl | 1 | 1997 | 69 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 14033 | 0.010 |
Why?
|
Life Tables | 1 | 1996 | 364 | 0.010 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 1997 | 184 | 0.010 |
Why?
|
Dimerization | 1 | 1996 | 891 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 386 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2007 | 11122 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1996 | 535 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2010 | 7859 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1997 | 2748 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2180 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 74213 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6075 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1997 | 13446 | 0.000 |
Why?
|